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Abstract
Background: The FA/BRCA pathway repairs DNA interstrand crosslinks. Mutations in
this pathway cause Fanconi anemia (FA), a chromosome instability syndromewith bone
marrow failure and cancer predisposition. Upon DNA damage, normal and FA cells
inhibit the cell cycle progression, until the G2/M checkpoint is turned off by the checkpoint
recovery, which becomes activated when the DNA damage has been repaired.
Interestingly, highly damaged FA cells seem to override the G2/M checkpoint. In this
study we explored with a Boolean network model and key experiments whether
checkpoint recovery activation occurs in FA cells with extensive unrepaired DNA damage.
Methods: We performed synchronous/asynchronous simulations of the FA/BRCA
pathway Boolean network model. FA-A and normal lymphoblastoid cell lines were used
to study checkpoint and checkpoint recovery activation after DNA damage induction.
The experimental approach included flow cytometry cell cycle analysis, cell division
tracking, chromosome aberration analysis and gene expression analysis through qRT-PCR
and western blot.
Results: Computational simulations suggested that in FA mutants checkpoint recovery
activity inhibits the checkpoint components despite unrepaired DNA damage, a
behavior that we did not observed in wild-type simulations. This result implies that FA
cells would eventually reenter the cell cycle after a DNA damage induced G2/M
checkpoint arrest, but before the damage has been fixed. We observed that FA-A cells
activate the G2/M checkpoint and arrest in G2 phase, but eventually reach mitosis and
divide with unrepaired DNA damage, thus resolving the initial checkpoint arrest. Based
on our model result we look for ectopic activity of checkpoint recovery components.
We found that checkpoint recovery components, such as PLK1, are expressed to a
similar extent as normal undamaged cells do, even though FA-A cells harbor highly
damaged DNA.
Conclusions: Our results show that FA cells, despite extensive DNA damage, do not
loss the capacity to express the transcriptional and protein components of checkpoint
recovery that might eventually allow their division with unrepaired DNA damage. This
might allow cell survival but increases the genomic instability inherent to FA
individuals and promotes cancer.
Keywords: DNA damage, Checkpoint recovery, Boolean network model
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Introduction
The molecular basis of the DNA damage response (DDR) has been largely elucidated
through the study of the rare chromosome instability syndromes (CIS) [1] which are
cytogenetically characterized by the spontaneous appearance of chromosome aberrations
(CA) as well as hypersensitivity to specific DNA damaging agents [2–4]. The best-known
CIS include Bloom syndrome (BS) which appears due to mutations in BLM helicase [5, 6]
and results in increased sister chromatid exchanges [7], Ataxia Telangiectasia (AT) that
shows particular clonal chromosome rearrangements as a consequence of mutations in
the checkpoint kinase ATM gene[8–11], and Fanconi anemia (FA) [12] whose phenotype
results from mutations in any of the genes that conform the FA/BRCA pathway [13–19]
and consists of chromatidic breaks, iso-chromatidic breaks and radial exchange figures
among chromosomes. Even if these breaks and radials are predominantly seen in FA, they
can also be observed in BS and AT [4, 20]. Although patients affected by CIS display phe-
notypic similarities, such as growth defects, compromised immunological system and an
increased risk to develop cancer [1, 20], each syndrome presents particular phenotypes
and pivotal data. Namely, BS shows sun sensitivity [5], AT presents progressive cerebel-
lar ataxia and oculo-cutaneous telangiectases [8], while FA is characterized by congenital
malformations and progressive bone marrow failure [21]. The products of these genes
interact in the cell’s DNA damage response [1], and thus the deficiency of any of these
proteins diminishes the efficiency of a cell to cope with DNA damage, leading to their
accumulation.
Given the critical role that these proteins have in the protection of the human genome,
certain authors have speculated that survival of CIS patients is an oddity and that
cells escaping apoptotic death do so by constitutively inducing alternative replication or
DNA damage tolerance pathways, which might contribute to the characteristic mutator
phenotypes observed in the CIS [22].
In the particular case of FA, cells are hypersensitive to agents that create DNA inter-
strand crosslinks (ICL), such as mitomycin C (MMC) or diepoxybutane (DEB) [21]. The
treatment of FA cells with MMC or DEB induces a blockage during the G2 phase of
the cell cycle and exacerbates the frequency of CAs, including double strand breaks
(DSBs) and radial exchange figures [23]. Biallelic mutations in at least one of 18 distinct
FANC genes can generate FA. The products of these genes interact in the so-called Fan-
coni Anemia/Breast Cancer (FA/BRCA) pathway [13–18], involved in the repair of the
DNA damage generated by intrinsic acetaldehydes and extrinsic ICL inducing agents.
Therefore, a deficiency in this pathway results in DNA damage accumulation that might
originate congenital malformations, uncontrolled hematopoietic cell death and cancer in
FA patients [24–27].
Over the years, the FA diagnosis assays and experimental approaches have shown that
a great proportion of FA cells succumb to DNA damage due to their inherent repair defi-
ciencies. However, some cells are able to tolerate high levels of DNA damage and progress
into mitosis despite a great amount of CAs. The mechanisms that allow the cells with
CAs to omit the DNA damage integrity checkpoints remain uncertain because the more
obvious candidate, the G2/M checkpoint, is considered to be properly activated in FA
cells [28–30]. Thus, the idea of a malfunctioning checkpoint in FA cells has been ruled
out and it is presumed that some other mechanisms are responsible for the checkpoint
override in FA cells with unrepaired DSBs.
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In recent times, an attenuated G2 checkpoint phenotype, characterized by low levels
of CHK1 (NP_001107594.1) and p53 (NP_000537.3), absence of the G2 phase arrest, and
arrival to metaphase with a large number of MMC-induced CAs has been described
in cells from adult FA individuals [31]. It has been suggested that the G2 checkpoint
attenuation could be an important contributor for the increased life expectancy of these
FA patients, and that the release of cells with unrepaired DSBs could promote neoplas-
tic transformation [31]. Nevertheless, since non-attenuated FA cells carrying unrepaired
DNA damage achieve a correct G2/M checkpoint activation [28–30], the aforementioned
mechanism seems to be a particular scenario rather than a general mechanism to enable
the resolution of the G2 checkpoint blockage.
Network modeling has been previously used with success to study the dynamics of
biological systems [32–37]. Particularly, we developed a Boolean network model (BNM)
for the FA/BRCA pathway [38], in which we observed that the inclusion of the check-
point recovery (CHKREC) node is crucial for the network correct function. In our model,
the CHKREC node represents the process that relieves the inhibition of the checkpoint
machinery over the mitosis-promoting factor (Cyclin B/CDK1) after a complete DNA
damage repair to allow further cell division [39–42]. This node comprises the G2 tran-
scriptional program that activates the expression of genes driving the G2/M transition
and the protein program that inactivates the γH2AX histone (NP_002096.1) and check-
point kinases [43]. We presumed that CHKREC activation might be releasing cells with
unrepaired DNA damage in FA mutants. To test this possibility, as well as to validate
the inclusion of the node itself in the FA/BRCA network, we used a simplified version
of our previously published FA/BRCA pathway BNM and experimentally determined if




The simplification of the FA/BRCA network was done by reorganizing the existing 28
nodes and 122 interactions [38], resulting in a deterministic BNM with 15 nodes and 66
interactions (Fig.1 and Table 1) that vastly simplifies the computational analysis while
maintaining the qualitative dynamical behavior of the original FA/BRCA network. The
simplification was made by collapsing the network components that share functions or
belong to a single pathway into one single node.Wewere careful to preserve all the impor-
tant functional categories of the network and made sure to recover the behavior of the
wild type and mutant networks. The modifications and simplification criteria are listed in
Table 2.
Simulations were performed for the wild type and all possible gain of function or null
mutants of the model with synchronous and asynchronous update regimes. Here we
report the simulations exploring checkpoint and CHKREC function in wild type and FA
core mutants. These null mutants were simulated fixing to zero the node of interest.
In these mutants we simulated the response to ICLs, whose presence is dependent on
the time that the system requires to turn it off. With our model we simulated two biolog-
ically relevant conditions, a short exposure to ICLs, which is supposed to be repaired fast
and efficiently by the FA/BRCA pathway (Fig. 2b) and a persistent exposure to damaging
agents, which is more difficult to face given the accumulation of damage and saturation
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Fig. 1 (See legend on next page)
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The latest FA/BRCA network. In response to an ICL, the FA/BRCA network responds by blocking the cell cycle
through the ATR and ATM checkpoint kinases and their downstream target p53. Similarly, the FA core
complex (FAcore) becomes activated and ubiquitinates FANCD2I complex, which in turn recruits DNA
endonucleases (NUC1 and NUC2). These endonucleases unhook the ICL generating a DNA adduct (ADD) and
a double strand break (DSB). Translesion synythesis (TLS) takes over the ADD while the DSB can be rejoined
either by FA/BRCA-dependent Homologous Recombination (FAHRR), FA/BRCA-independent Homologous
Recombination (HRR2), or by the error prone Non-Homologous End-Joining (NHEJ) pathways. Finally, we
predict that the CHKREC node, composed by the G2/M transcriptional program and checkpoint recovery
proteins, turns off the checkpoint and DNA repair proteins. Rectangles represent proteins or protein
complexes, pointed arrows are positive regulatory interactions, and dashed lines with blunt arrows are
negative regulatory interactions. Readers may refer to [38] for a more detailed description of the FA/BRCA
pathway
of the DNA repair pathway (Fig. 2c). The response to short ICL exposure was simulated
in both the wild type (Fig. 2b) and FAcore mutant (Fig. 2d) with the ICL value ON only
at the starting time step; whereas a continuous exposure to DNA damage was simulated
fixing the ICL value to 1 during the entire simulation. We performed exhaustive searches
of all possible trajectories and attractors in the system.
Implementation
The current FA/BRCA network is available through the supplementary file FAnetwork.r
this file has been tested using R (v3.1.1) package BoolNet (v1.63) [66]. Additionally, the
SBML-qual implementation of the model obtained by using the toSBML() function of
BoolNet is provided as the supplementary file FAnetwork.sbml. The generated file was
validated using the online service at http://sbml.org/Facilities/Validator/.
Table 1 Boolean functions for the nodes in the FA/BRCA network
RULES REFERENCES
ICL ← ICL ∧ ¬ DSB [38]
FAcore ← ICL ∧ (ATR ∨ ATM) ∧ ¬ CHKREC [14, 16, 44–46]
FANCD2I ← FAcore ∧ ((ATR ∨ ATM) ∨ ((ATR ∨ ATM) ∧ DSB)) ∧ [47–49]
¬ (CHKREC)
NUC1 ←ICL ∧ FANCD2I [50]; [38]
NUC2 ← (ICL ∧ (ATR ∨ ATM) ∧ ¬ (FAcore ∧ FANCD2I)) ∨ [51]; [38]
(ICL ∧ NUC1 ∧ p53 ∧ ¬(FAcore ∧ FANCD2I))
ADD ← (NUC1 ∨ NUC2 ∨ (NUC1 ∧ NUC2)) ∧ ¬ (TLS) [47, 50, 51]
DSB ← (NUC1 ∨ NUC2) ∧ ¬ (NHEJ ∨ FAHRR ∨ HRR2) [50, 52]
TLS ← (ADD ∨ (ADD ∧ FAcore)) ∧ ¬ (CHKREC) [53, 54]
FAHRR ← DSB ∧ FANCD2I ∧ ¬ (NHEJ ∧ CHKREC) [53, 54]
HRR2 ← (DSB ∧ NUC2 ∧ NHEJ ∧ ICL ∧ ¬ (FAHRR ∨ CHKREC)) ∨ [38]
(DSB ∧ NUC2 ∧ TLS ∧ ¬ (NHEJ ∨ FAHRR ∨ CHKREC))
NHEJ ← (DSB ∧ NUC2 ∧ ¬ (FAHRR ∨ HRR2 ∨ CHKREC)) [49, 52, 55–57]
ATR ←(ICL ∨ ATM) ∧ ¬ CHKREC [58–60]
ATM ← (ATR ∨ DSB) ∧ ¬ CHKREC ∨ FAcore [61, 62]
P53 ← ((ATR ∨ ATM) ∨ NHEJ) ∧ ¬ CHKREC [58, 63, 64]
CHKREC ← ((TLS ∨ NHEJ ∨ FAHRR ∨ HRR2) ∧ ¬ DSB ) ∨ [52, 53];
((¬ ADD) ∧ (¬ ICL) ∧ (¬ DSB) ∧ ¬ (CHKREC)) [38, 65]
Key references are included. Full discussion of interactions can be found in [38]
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Table 2 Network model simplification criteria
Node in the Nodes in the Simplification criteria
original BNM simplified BNM
ICL ICL Unchanged node
FANCM, FAcore FAcore ICL recognition proteins working
together in the upstream FA/BRCA
pathway
FANCD2I FANCD2I Unchanged node
MUS81 NUC1 Nuclease mediated
ICL incision
XPF, FAN1 NUC2 Nuclease mediated
ICL incision
ADD ADD Unchanged node
DSB DSB Unchanged node
ATR, CHK1, H2AX ATR These proteins act in the
Checkpoint pathway
ATM, CHK2, H2AX ATM These proteins act in the
Checkpoint pathway
p53 p53 Unchanged node
PCNATLS TLS This is only a change in name
FANCJMLH1, MRN, BRCA1, FAHRR These proteins act in the
FANCD1N, RAD51, HRR, Homologous Recombination
ssDNARPA Repair pathway
—— HRR2 New node representing the
alternative Homologous
Recombination Repair Pathway
KU, DNAPK, NHEJ NHEJ These proteins act in the
Non-Homologous End-Joining
DNA repair pathway
USP1, CHKREC CHKREC Global negative regulators
of the FA/BRCA pathway
Cell culture and treatments
Lymphoblastoid cell lines from FA-A VU817 (kindly donated by Dr. Hans Joenje, VU
University Medical Center) and normal NL-49 (generated in our institution under writ-
ten informed consent) were maintained in RPMI 1640 medium supplemented with 10 %
fetal calf serum, 1 % non-essential aminoacids and 1 % sodium pyruvate (all from GIBCO,
Waltham, Massachusetts, USA). During experiments 300,000 cell/ml were exposed to 10
ng/ml ofMMC (Sigma-Aldrich Co, St. LouisMO, USA) for 24 h and harvested to evaluate
different markers. All the experiments were run by triplicate.
Chromosome aberration and nuclear division index analysis
For chromosome aberration analysis, colchicine (Sigma-Aldrich Co, St. Louis MO, USA)
(final concentration of 0.1 μg/ml) was added to cell cultures one hour before harvesting
with the conventional method. Twenty five metaphases per experimental condition were
scored by recording the number of chromatid breaks, chromosome breaks and radial
figures. A cytokinesis block assay, using 3 μg/ml of cytochalasin B (Sigma-Aldrich Co,
St. Louis MO, USA), was implemented to obtain binucleated and tetranucleated cells:
after exposing the cells to MMC for 24 h, they were washed, reincubated with fresh






Fig. 2 FA network simulations. a The current information regarding the FA/BRCA pathway have not
uncovered the mechanism that allows the resolution of the G2/M checkpoint after DNA damage and further
cell division. b Trajectories and attractor of the wild type FA/BRCA network under an ICL pulse. In this
simulation wild type cells repair DNA damage through the FA/BRCA pathway and arrive to CCP attractor after
activating the CHKREC node once the damage has been fixed. The inclusion of the CHKREC node, as a
checkpoint negative regulator, allows to explore the mechanisms behind cell division after checkpoint
resolution. c In response to a continuous ICL DNA damage, wild type cells arrive to a CCA attractor with
activation of the checkpoint and DNA damage repair nodes,the CHKREC node becomes eventually activated
in this attractor. d Under and ICL pulse FAcore mutant cells activate the NHEJ pathway to repair DNA damage
and arrive to a CCP attractor. e In response to a continuous ICL DNA damage, FAcore mutant cells
concomitantly activate the checkpoint and the CHKREC nodes. Node names are indicated at the topmost
row. The leftmost column indicates simulation time steps in arbitrary units. Time steps corresponding to
trajectories are indicated and time steps corresponding to attractors are indicated by shaded gray and “ATT”.
For illustrative purpose cyclic attractors are represented twice
cytochalasin B for another 24 h and harvested using a 7:1 methanol:acetic acid fixative.
Five hundred cells were scored to quantify the number of micronuclei, mononucleated,
binucleated and tetranucleated cells in every experimental condition [67].
Flow cytometry analysis
To determine cell cycle distribution and mitotic index the cells were fixed with 70 %
ice-cold ethanol, washed twice with PBS (GIBCO, Waltham, Massachusetts, USA) and
permeabilized with 0.1 % PBS 1X + Triton X100. The MPM2 antibody (CellSignaling,
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Boston MA, USA) was used to determine the number of cells in M phase. The antibody
was marked with the labeling anti-mouse Alexa-Fluor 488 fluorophore from the Zenon
Tricolor Mouse IgG Labeling Kit # 1 (Invitrogen, Carlsbad, CA, USA) according to man-
ufacturer instructions. The cells were incubated during 1 h with the antibody, washed
with PBS/NGS 10 % and counterstained with propidium iodide (Sigma-Aldrich Co, St.
Louis MO, USA). A total of 20,000 events were scored in a FACSCan (Beckton Dickinson,
Ontario, CA) cytometer and the analysis was performed using the CellQuest program
version 3.2.1.
RNA extraction and quantitative real-time PCR (qRT-PCR)
Total RNA was obtained employing the combined method of TRIzol (Invitrogen,
Carlsbad, CA, USA) followed by RNeasy mini procedure (Qiagen, Valencia, CA, USA),
according to manufacturer instructions. Before retro-transcription, 1 μg of total RNA
was treated with 0.1 U RNase-free DNase I (Invitrogen, Carlsbad, CA, USA) in 20
mM Tris-HCl, pH 8.3, 50 mM KCl, and 1 mM MgCl2 for 15 min at room tempera-
ture. The enzyme was inactivated by adding EDTA to a final concentration of 1 mM
followed by incubation at 65°C/10 min. Total RNA was retro-transcribed into cDNA
using the Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics, GmbH,
Mannheim, Germany) using anchored-oligo (dT) 18 primer (50-pmol/μL) and Random
hexamer primer (600 pmol/μL), protector RNase Inhibitor (20 U), and Transcriptor
Reverse Transcriptase (10 U). Total RNA and cDNA were quantified using a Nanodrop
ND 1000 spectrophotometer (Nanodrop Technologies,Wilmington, DE, USA). Real-time
quantitative-PCR (qRT-PCR) was performed by duplicate for each cell line, treatment
and biological repeat using 2 μg of cDNA per reaction with the Universal Probes sys-
tem (Roche Diagnostics, GmbH, Mannheim, Germany) and the Light Cycler Taq Man
Master kit (Roche Diagnostics, GmbH, Mannheim, Germany). 7SL (NR_002715.1), β2
microglobulin (NM_004048.2) and β-actin (NM_001017992.3) gene expression were
used as reference. Primers for each gene were designed on-line with the ProbeFinder
Software (http://www.universalprobelibrary.com) and manufactured by the Sequencing
and Synthesis Unit (IBT, UNAM). The qRT -PCR was carried out in a Light Cycler 2.0
Carousel Roche equipment.
Protein extraction and immunoblot
Cells were harvested in TLB lysis buffer supplemented with the Complete C protease
and phosphatase inhibitors mix (Roche, Mannheim, Germany). Quantification was made
with Bradford ready to use reagent (Biorad, Hercules, CA). Total cell protein (10μg) was
separated by 12 % SDS- PAGE, transferred to nitrocellulose membrane (Biorad, Hercules,
CA) and incubated with primary antibodies overnight at 4°C followed by incubation with
goat-anti-mouse (Invitrogen, Carlsbad, CA, USA) or goat-anti-rabbit (Invitrogen, Carls-
bad, CA, USA) HRP tagged secondary antibodies. Bands were visualized with Lumigen
on Amersham Hyperfilm (GE Healthcare, Fairfield, CT, USA). Primary antibodies used
are listed below: anti-WEE1 (NP_001137448.1) (Abcam, Cambridge, UK), anti-WIP1
(NP_003611.1 ) (Abcam, Cambridge, UK), anti-pCHK1 Ser345 (Cell Signaling, Boston
MA, USA), anti-γH2AX (Genetex, Irvine, CA), anti-p21 (NP_000380.1) (Genetex, Irvine,
CA), anti-MYT1 (NP_004526.1) (Genetex, Irvine, CA), anti-Aurora A (NP_003591.2)
(Abcam, Cambridge, UK), anti-CDC25B (NP_001274445.1) (Genetex, Irvine, CA) and
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anti-PLK1 (NP_005021.2) (Abcam, Cambridge, UK); anti-GAPDH (NP_001243728.1)
was used as loading control (Genetex, Irvine, CA).
Statistical analysis
Experimental groups were compared using two way ANOVA, followed by Tukey’s post-
hoc test. A difference was considered significant if p < 0.05.
Results
FA/BRCA network analyses show that CHKREC promotes cell division in FAmutants with
DNA damage
Appropriate function of the FA/BRCA pathway guarantees the complete repair of ICLs
and correct checkpoint activation impedes cell division upon DNA damage detection
[68]. Therefore an accurate model of the FA/BRCA pathway should show cell division
after complete DNA damage repair in wild-type cells. In our previous work [38], we
demonstrated that the inclusion of the CHKREC node is crucial to reproduce correctly
the DNA repair behavior. Without CHKREC, as a negative regulator of the checkpoint
nodes, the network remains in a permanent arrest after DNA repair (Fig. 2a). Hence,
CHKREC provides a mechanism that allows the cell to resolve the checkpoint (Fig. 2b).
We performed synchronous and asynchronous simulations with the updated and sim-
plified version of the FA/BRCA network and observed that the simplified model is able
to reproduce all the previously reported results (Fig. 2b and data not shown). Only
synchronous simulations are shown given that asynchronous update results in complex
trajectories, while preserving the attractors of the original model [38]. Hence, we decided
to use our new version of the network model to deeply study the role of CHKREC in the
abnormal behavior of FA cells.
Ninety percent of FA patients carry mutations in one of the components of the FA
core complex, including FANCA (NP_000126.2), FANCB (NP_001018123.1), FANCC
(NP_000127.2), FANCE (NP_068741.1), FANCF (NP_073562.1), FANCG (NP_004620.1),
FANCL (NP_001108108.1) and FANCM (NP_001295063.1) [21]. Hence, to study the role
of CHKREC in FA cells, we simulated the FA core complex mutant, represented in our
model by the FA core node, and compared its dynamic behavior to a wild type network.
Our simulations recapitulate two cellular behaviors relevant to DNA damage that are
represented by two specific attractors.We denominated them as the cell cycle progression
attractor (CCP), and the cell cycle arrest attractor (CCA). The CCP attractor is charac-
terized by the CHKREC-mediated inactivation of every checkpoint node, namely ATM,
ATR and p53, followed by CHKREC oscillations. It has been experimentally proven that
CHKREC is required for the activation of the genes and proteins that release the G2/M
checkpoint to allow cell cycle progression [39, 41–43]. Hence, the cyclic behavior of the
CHKREC node in the CCP attractor represents the periodical transition into the cell
cycle, and should ideally be reached when DNA damage has been repaired. In our simu-
lations both wild type and FA core mutant reach the CCP attractor after an ICL pulse of
damage (Fig. 2b,d).
On the other hand, CCA is a cyclic attractor that represents a checkpoint mediated
cell cycle arrest that is reached when DNA damage persists and the cell is engaged in
a DNA repair process. Once the system has reached CCA there is recurrent activation
of the DNA damage repair and the checkpoint nodes, accompanied by CHKREC node
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activation, thus CHKREC activation might occur during an ongoing CCA but the cell
would not divide unless the checkpoint nodes are turned off, which in turn would not
occur until the DNA damage has been completely removed. Although more than one
combination of node activation patterns can be interpreted as a CCA attractor, all such
patterns share the activation of the DNA damage and the checkpoint nodes followed by
activation of CHKREC.
In our simulations with a constant ICL damage the wild type (Fig. 2c) and FA core
mutant (Fig. 2e) networks reach a CCA attractor with checkpoint and CHKREC activa-
tion. In the wild-type simulation we observe that the checkpoint components are never
completely down-regulated in presence of DSBs or during the ICL stimulus, however the
FA core mutants have a transient state in which DSBs are activated and the checkpoint
components are inactivated, as a response to CHKREC activation in the previous step.
This result suggests that FA cells might overcome, through CHKREC activation, the cell
cycle arrest despite unrepaired DNA damage.
Our modeling approach has advanced many interesting predictions about the effect of
FA mutations during the DNA repair process. In the next section we focused on the one
that we considered more general and important. Namely, that CHKREC inhibition over
the checkpoint components might allow the division of FA cells even if DNA has not been
completely repaired. Hence, we verified if CHKREC activation might occur in FA cells
after DNA damage induction allowing their eventual cell division, even in the presence of
unrepaired DNA damage.
CHKREC components are activated in FA cells with unrepaired DNA damage
Cells should divide only after successful and thorough DNA repair [68, 69], which is
achieved through efficient DNA repair and accurate G2/M checkpoint activation. FA core
mutants are DNA repair deficient but G2/M checkpoint proficient, therefore the fact
that they are able to divide despite a strong G2/M checkpoint activation and carrying
unrepaired DNA damage is remarkable. Our BNM anticipates that turning off a DNA
damage-induced G2/M checkpoint might occur through CHKREC activation, thus allow-
ing cell division. We verified this prediction by following the transit through G2 and M
phases in the presence of DNA damage in wild type (NL49) and FA-A (VU817) cell lines
exposed to MMC.
First, we evaluated checkpoint activation using several markers. Using PI cell cycle flow
cytometry analysis we observed that treatment with MMC induces an over time increase
in the number of FA-A cells arrested in G2 when compared to normal cells (Fig. 3a, left
panel), as well as a reduction in the number of mitotic cells (MPM2+ cells in Fig. 3a, right
panel), accompanied by a lag of approximately 6–12 hours in the peak of MPM2+ cells in
both MMC-treated FA and normal cells, compared to their respective untreated controls
(see 24 and 30 hrs of MMC treatment). However normal MMC treated cells have the
highest peak as they deliver a bigger number of cells intoM phase. This lag might indicate
that, while repairing the MMC-induced DNA damage, the cells postpone the resolution
of the G2 checkpoint. This arrest is shorter in normal cells given that they repair in a
more efficient way thus having a more prominent contribution to the mitotic index when
compared to FA cells. The highest percentage of MPM2+ cells of MMC treated normal
cells might indicate a sharp delivery of previously G2 arrested cells, contrary to a smooth
delivery of untreated normal cells.
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A
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Fig. 3 FA cells arrest at G2 phase in response to MMC. a Flow cytometry analysis showing accumulation of
FA cells in G2 in response to MMC (left panel) and diminished number of FA mitotic cells compared to
normal cells (right panel). b FA cells activate CHK1 kinase in response to MMC treatment. c FA cells increase
the expression of p21 mRNA as showed by qRT-PCR analysis (n = 3 independent experiments, p< 0.05)
In FA-A cells treated with MMC we also observed increased CHK1 phosphoryla-
tion (Fig. 3b), a classical checkpoint activation marker, along with increased p21 mRNA
expression (Fig. 3c). p21 is the main p53 target and is an important player for cell cycle
arrest. The expression of this gene shows that the cell is committed to cell cycle arrest
and its continuous expression is necessary to prevent cell division in cells that carry unre-
paired chromosomes [68, 69]. These experiments show that FA-A cells are able to activate
mechanisms that halt cell cycle progression at the G2 phase uponDNAdamage induction.
We then evaluated if FA-A and normal cells were able to divide despite unrepaired DNA
damage. We quantified the cell division capacity after MMC treatment by performing a
cytokinesis block assay with cytochalasin B (CB). Meanwhile, the DNA damage was eval-
uated by recording the frequency ofmicronuclei inmultinucleated cells and the frequency
of CAs in metaphase spreads.
CB experiments showed that treatment with MMC increased the proportion of
mononucleated cells (cells that still do not divide due to G2 halt) (Fig. 4a upper panel),
while the number of binucleated cells irrespective of the cell type (NL49 or VU817) or the
addition or not of MMC remained the same (Fig. 4a middle panel). Remarkably, MMC
treatment reduced significantly the number of tetranucleated FA cells (Fig. 4a bottom
panel). On the other hand, the analysis of metaphase spreads showed that FA-A cells
reached mitosis with a significantly higher frequency of CAs (Fig. 4b upper panel) than
normal cells, and were able to divide despite unrepaired DNA damage, i.e. micronuclei
(Fig. 4b bottom panel). These experiments show that FA-A cells first arrest in response to
DNA damage but eventually reach cell division regardless of CA.
As suggested by our model, CHKREC activation could be relieving cell cycle arrest
mediators, leading the cell to divide. To determine if the CHKREC components became
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Fig. 4 FA cells divide despite MMC treatment and cell cycle arrest. a The number of mononucleated cells
(upper panel), binucleated cells (middle panel) and tetranucleated cells (bottom panel) was quantified after
exposure to MMC (24 h) and Citochalasin B (48 h). The number of basal binucleated and tetranucleated cells
was counted without Citochalasin B treatment and rested from the total number (data not shown). b Despite
G2 arrest FA cells arrive to mitosis and divide with unrepaired DNA damage as demonstrated by two
independent DNA damage analyses, increased chromosome aberrations (upper panel) and increased
micronuclei in cells that have reached one division (bottom panel) (n = 3 independent experiments, p< 0.05)
active in MMC treated FA cells, thus allowing their eventual division, we evaluated some
molecular markers relevant for CHKREC and cell division. We analyzed by qRT-PCR the
expression of the G2 transcriptional program, whose protein products are necessary for
the G2/M transition; namely, Cyclin A2 (CCNA2, NM_001237.3 ), Cyclin B1 (CCNB1,
NM_031966.3), WIP1 (PPM1D, NM_003620.3), FOXM1 (NM_001243088.1) and PLK1
(NM_005030.4) [16, 27, 70]. Our results show that the expression levels of these genes
remain unaffected in FA-A cells, compared to wild type cells (Fig. 5a–e). Importantly,
these genes are expressed in a cell cycle-dependent manner and are necessary for G2
phase completion [43], thus if they remain unchanged after MMC treatment, suggests





Fig. 5 FA cells have a gene expression pattern compatible with checkpoint resolution despite DNA damage.
Gene expression analysis of the genes belonging to the G2 transcriptional program did not show differences
in the expression of these genes despite MMC treatment. Cyclin A2 (a), Cyclin B1 (b), WIP1 (c), FOXM1 (d) and
PLK1 (e) (n = 3 independent experiments). No statistically significant differences were found in the gene
expression patterns among groups
that this program remains poised for resolution of the G2 cell cycle blockage in FA cells,
even with incomplete DNA repair.
Our BNM and these experimental results indicate that FA-A cells are able to block the
cell cycle progression in G2 but eventually recover. Simulations with the BNM showed
also that co-activation of G2 checkpoint and CHKREC components might occur in
arrested FA cells, therefore, additional to CHK1, we evaluated other protein markers to
asses key G2 checkpoint and CHKREC activation 24 h after MMC treatment. The G2
checkpoint markers included:WEE1, MYT1, p21 and γH2AX; while CHKREC activation
markers consisted of: WIP1, Aurora A, PLK1 and CDC25B.
We observed that CHK1 activity is increased after MMC treatment in FA-A cells
(See Fig. 3b), but other checkpoint components, namelyWEE1, p21 and γH2AX (Fig. 6a),
have reduced levels. Remarkably, we also observed concomitant activation of CHKREC
proteins PLK1, CDC25B and Aurora A (Fig. 6b) in damaged FA cells. Thus indicating
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Fig. 6 FA and normal cells co-express checkpoint and CHKREC proteins. aWestern Blot analysis of
checkpoint proteins. bWestern blot analysis of CHKREC proteins. FA cells increase the amount of some G2
blockage proteins, but have a reduction in others. Although CHK1 (Fig. 4b) and MYT1 show increased signal,
WEE1, γH2AX and p21 protein appear as diminished in FA cells, this weakens the checkpoint blockage,
which is eventually overwhelmed by CHKREC signaling (n = 3 independent experiments, see also Fig.7)
that despite a strong CHK1 signal that leads to cell cycle progression blockage, FA-A cells
co-express the components that might dampen the DNA damage signaling and allow
an eventual CHKREC despite an elevated amount of CA. In agreement, we observed in
FA-A cells reduced levels of the histone γH2AX, a DNA damage signaler andWIP1 phos-
phatase target. Notably, we also observed weakening of p21 protein signaling, which has
also been correlated with CHKREC activation [71]. These results suggest that signaling of
DSBs might be weakened at this time-point, triggering full CHKREC activation and cell
division despite a strong CHK1 signaling and high levels of CAs (relative protein amount
for all the markers can be seen in Fig. 7).
These experimental results show that the CHKREC is being activated in FA cells car-
rying CA to a similar extent as normal undamaged cells, this CHKREC induction might
allow the escape of G2 with unrepaired DNA damage and cell division. The correlation
between the nodes of the network and the experiments performed can be seen in Table 3.
Discussion
Several methods are used to model and analyze biological systems [72–74]. These meth-
ods analyze the topology of the network or the kinetics of the system specifying the flux
of information through a continuous model or a logical model [74].
Continuous models represent the temporal dynamics of biochemical processes with
considerable detail, but are highly dependent on the values of free parameters (initial
protein concentrations and rate constants), whose estimation might be challenging as
networks get larger [73, 75]. Logical models rely on qualitative knowledge [72]. Logical
BNM are the minimal computational model necessary to obtain a meaningful idea about
the dynamics of a regulatory network and are useful when detailed enzymatic informa-
tion is missing [75, 76]. Many molecular regulatory systems show binary behaviors or
act like bistable switches [77], thus the binary or discrete representation of BNM can
adjusts to them and predict sequence patterns of proteins and gene activities with less








Fig. 7 Western Blot densitometry analysis. Checkpoint proteins (a–e) and CHKREC proteins (f–i). (n = 3
independent experiments). No statistically significant differences were found in the protein expression
patterns among groups
parameters than a continuous model. Although BNM have been used for modeling sev-
eral systems [32–37], they might not be appropriate if the system has continuous values
or if knowledge on the network architecture is lacking [75].
We have developed a binary BNM that recapitulates in a simple manner the response
to ICLs mediated by the FA/BRCA pathway [78]. Given that the different components of
the network might remain unchanged, up-regulated or down-regulated instead of binary,
an additional representation of the FA/BRCA network as a discrete ternary logical net-
work might be also feasible [79], however a binary BNM resulted optimal given that
our system presents gene expression showing a pattern of binary states (over-expressed,
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Table 3 Correlation between experimental validations and nodes in the FA/BRCA BNM
Process Nodes in the Experimental markers Validated role References
FA/BRCA BNM used in this study in the BNM








DNA repair ADD γH2AX, ICLs are unhooked [13, 21]
intermediaries DSB CA in metaphase by FA core-recruited
spreads DNA-endonucleases
that generate a DSB
and an ADD
Downstream TLS Non-evaluated The ADD and DSB [14, 15, 18, 54]






Alternative HRR2 Non-evaluated FA cells use [49, 56]





Checkpoint ATR Cell cycle arrest Upon DNA damage [27, 28, 31]
ATM in G2, pCHK1-S341, normal and FA
p53 p21 gene expression, cells activate
MYT1, WEE1, p21 the G2/M checkpoint
proteins
Checkpoint CHKREC MPM2 mitotic index, The checkpoint [83, 84] and this work
recovery cytokinesis block assay, is inactivated by
G2/M transcriptional CHKREC after
program, WIP1, PLK1, DNA repair
CDC25, Aurora A FA cells seem to have
proteins a lower threshold for
CHKREC activation
compared to normal cells
under-expressed) or protein concentrations that can reach a saturation regime (full acti-
vation) or remain in small concentrations (inactive). In addition the change to a ternary
system would increase the possible states of the system from 32,768 to 14,348,907 states,
thus augmenting the computational work.
Our modeling of the FA/BRCA regulatory network has led to the observation that
CHKREC is a mechanism conferring stability to this system inwild type and FA cells ([38]
and this work). CHKREC is fully activated once the G2/M checkpoint has been satisfied
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leading to the division of the cell [42]. CHKREC is mainly composed of phosphatases,
such as WIP1, that inactivate the G2 checkpoint and protein-kinases that release the
cell cycle blockage, such as Aurora A and PLK1 [41, 80]. Notably, the negative circuits
mediated by CHKREC seem to be a central part of the control system of the FA/BRCA
network: they are activated when the system induces the expression of its own inhibitors,
and are necessary to attenuate the stimulatory signals arising from DNA damage (Fig. 1
and Fig. 2).
When simulating mutants, we noticed that CHKREC function inactivates the check-
point in FA core mutants despite unrepaired DNA damage, thus resolving the
G2/M checkpoint arrest and allowing cell division. Therefore we should notice ele-
vated/unchanged levels in the expression, quantity or activity of CHKREC components
in FA cells with damaged DNA compared to undamaged normal cells, indicating
that FA cells conserve checkpoint resolution capacity and are poised for cell divi-
sion when the DNA damage checkpoint response ceases. To test the function of the
CHKREC node, we experimentally evaluated the cell division capacity as well as check-
point/CHKREC activation in FA-A lymphoblasts after induction of DNA damage with
MMC.
We evaluated the G2 blockage and found accumulation of FA-A cells into the G2 phase
compartment after induction of DNA damage (Fig. 3a left panel) and a reduced num-
ber of FA-A mitotic cells in comparison to normal cells after MMC exposition (Fig. 3a
right panel). We also detected high CHK1 phosphorylation levels (Fig. 3b) as well as high
p21 gene expression (Fig. 3c) in FA-A cells. CHK1 is a key protein kinase that transduces
the DNA damage signaling, and p21 is a direct p53 transcription target, therefore an
increase in p21 activation is the result of p53-increased activity, thus demonstrating that
FA cells achieve a correct activation of the checkpoint that blocks the G2/M transition
[27, 28]. p21 is a negative regulator of Cyclin B/CDK1 complex and is necessary to avoid
the G2/M transition in presence of DNA damage [81]. Thus, CHK1 phosphorylation and
p21 expression augment when a cell is exposed to DNA damaging agents and would be
expected to drop-off once a cell has repaired the DNA damage [82].
When we evaluated the cell division capacity in a CB block assay, we did not observe
differences in the frequency of binucleated cells between normal and FA-A cells (Fig. 4
middle panel), although MMC limited tetranucleated cells production in both cell types
(Fig. 4c bottom panel). These results show that, under these experimental conditions,
both FA-A and normal cells divide to a similar extent after induction of DNA damage by
MMC.
The capability of FA cells to divide with unrepaired DNA damage was evaluated by
quantifying the frequency of DNA damage induced by MMC in cells committed to divide
by scoring CAs in metaphase spreads, as well as in cells that have already performed cell
division by quantifying the micronuclei observed in binucleated and tetranucleated cells.
Our results showed, in both assays, that FA-A cells exposed to MMC carry significant
DNA damage during mitosis and, nonetheless divide (Fig. 4b).
Our BNM allowed us to propose that CHKREC function in FA cells might ignore
in a certain level the presence of unrepaired DNA damage and could be responsible
for their division, therefore we expected that normal and FA-A cells would have simi-
lar activation levels of the CHKREC components. To test this possibility, we measured
the expression of the G2 transcriptional program genes that promote CDK activity and
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progression into mitosis, namelyWIP1, Cyclin A2, Cyclin B1, PLK1, CDC25 and FOXM1
[43] (Fig. 5a–e) and evaluated the activation of some of the proteins involved in check-
point and CHKREC (Fig. 6). In the first assay we observed that the expression of the genes
that enable CHKREC and cell division are similar in normal/undamaged cells and dam-
aged FA cells, even when FA cells carry a higher number of CAs. In addition, we observed
co-expression of checkpoint and CHKREC proteins in FA cells treated with MMC (Fig. 6
and 7), indicating that damaged FA cells are poised for an eventual cell division despite
DNA damage (Fig. 8).
Checkpoint activation, cell cycle arrest and DNA repair require a great number of
protein posttranslational modifications for their establishment. Dedicated enzymes that
remove these modifications or degrade modified proteins allow checkpoint silencing and
recovery [84]. WIP1 phosphatase and PLK1 kinase emerge as the coordinators of check-
point silencing and recovery, respectively, however if there exist a certain order in their
activation remains elusive. In general terms for cell division, Cyclin B levels must gradu-
ally increase, while CDC25 phosphatase should remove any inhibitory phosphorylation of
CDK1, thus promoting Cyclin B/CDK1 complex formation and mitotic entry. However,
after induction of DNA damage, the G2 checkpoint inhibits CDK1 activity through p21,
whilst WEE1 and MYT1 kinases degrade CDC25, avoiding mitotic entry [42, 70, 80].
WIP1 phosphatase dephosphorylates ATM, p53, CHK1, CHK2, γH2AX and the
p(S/T)Q motif originally modified by ATM and ATR [85, 86]. During CHKREC, Aurora-
A kinase activates PLK1, which in turn targets WEE1 for proteasomal degradation and
releases CDK1 from blockage [42, 87–89], in addition PLK1 interferes with CHK1,
CHK2 and p53 stability, thus it also has an active role turning-off the DNA damage
checkpoint [40].
Fig. 8 CHKREC components activation in normal and FA cells. After DNA damage induction, the cell activates
the DNA damage integrity checkpoints, the G2/M checkpoint specifically avoids the transition of the cell
from G2 to M phase with unrepaired DNA damage. Once the DNA has been repaired, the G2/M checkpoint is
satisfied and the cell activates the CHKREC, a process that inactivates checkpoint proteins and promotes cell
division. Upper panel. Normal cells activate CHKREC with repaired chromosomes. Bottom panel. FA cells
activate CHKREC despite unrepaired chromosomes. The specific mechanism triggering this inappropriate
CHKREC activation in FA cells remains unknown
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In Fig. 6b we observe that the concentration of WIP1 is increased in normal cells and
reduced in FA cells; on the contrary PLK1 is reduced in normal cell and increased in
FA cells. Interestingly, PLK1 activity is redundant in unperturbed mitotic entry whereas
it becomes essential in CHKREC after DNA damage [88, 89], consistently it is activated
in our experiments in damaged FA-A cells. As FA cells carry spontaneous unrepaired
DNA damage, this implies that their transition through G2 is always perturbed to a
certain extent, thus PLK1 should become essential for FA cells survival. Given this,
PLK1 over-activation must be involved in the adaptation of FA cells to DNA dam-
age. Recent evidence shows that PLK1 activity is gradually increased during an ongoing
DNA damage-induced cell cycle arrest and if the activity of the kinase exceeds beyond
a certain level, the cell progresses to mitosis despite DNA damage persistance [83]. G2
checkpoint recovery might thus represent a checkpoint adaptation, where DNA dam-
age triggers an arrest whose duration is not necessarily conditioned by DNA repair [84].
Regarding this, PLK1 might have a more critical role than WIP1 in the delivery of FA
cells with unrepaired DNA damage from the G2 arrest, or WIP1 is acting before than
the time-point that we are evaluating in this assays, hence we are not able to detect
WIP1 protein (Fig. 6b). The distinction between both possible scenarios deserves further
research.
A final aspect to be considered are the findings of Ceccaldi and coworkers [31], who
described an attenuated G2/M checkpoint activity in adult FA individuals that, con-
comitantly to low CHK1 and p53 protein levels, allowed the escape of unrepaired DNA
damage. Although they demonstrate that downregulation of the ATR-CHK1 axis is
responsible for this phenotype, it remains elusive if this reduced checkpoint activity might
be due to CHKREC over-activation or ectopic activity. In this study we set the basis to
explore this possibility in FA individuals with an attenuated G2/M checkpoint and the
general mechanism allowing G2/M resolution in non-attenuated FA individuals. Further,
modeling the full interaction between the G2/M checkpoint and CHKREC, as well as a
systematic inhibition of CHKREC components in FA cells, will shed light into the intricate
interactions between these two processes.
Our results show that highly damaged FA-A cells preserve the capacity to divide after a
cell cycle arrest induced by DNA damage, a result that is consistent with our BNMFA core
null mutant simulations. Nonetheless, the definition of the specific trigger for cell division
remains unknown. To our judgment, the CHKREC hypothesis became the most rele-
vant hypothesis emerging from our BNM given that CHKREC promotion might enable
cell survival and amelioration of blood cell counts in pancytopenic FA patients, however
CHKREC overexpression might also lead to exhaustion of the hematopoietic stem cell
compartment as well as selection of malignant clones. Therefore, the thorough study of
this process becomes relevant for the understanding of hematopoiesis and carcinogenesis
in a FA background.
Conclusion
In this study we propose through network modeling that CHKREC, a program neces-
sary for cell division after DNA damage, becomes activated in FA core mutant cells with
unrepaired DNA damage. We experimentally show that highly damaged FA-A cells have
CHKREC expression levels similar to those observed in normal undamaged cells, thus
FA-A cells might ignore the presence of broken chromosomes through this process. We
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observed that despite a prominent G2 arrest after MMC exposure, FA cells were able to
activate the mechanisms that allow cell division (Fig. 8).
FA cells are prone to apoptosis due to their DNA repair defects, however a great quan-
tity of them divide in spite of unrepaired DNA damage, thus allowing the survival of
FA individuals. The study of the mechanisms that allow FA cells to survive may help
to develop novel therapies designed to promote hematopoiesis, as well as to avoid the
division of malignant clones in FA patients.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AR, LM and SF conceived the project; AR, DS and EA developed the BNM; AR, LT, UJ, DS, BGT, EC and AMS performed
experiments; RO and POW provided essential reagents; LM coordinated computational work; SF coordinated laboratory
work. All authors read and approved the final manuscript.
Acknowledgements
Authors thank our colleagues at Dr. Frías’ laboratory for insightful discussions and Anet Rivera Osorio for invaluable
assistance with experiments. This work was supported in part by grants from Universidad Nacional Autónoma de México
PAPIIT IN200514 and IA201713, and Instituto Nacional de Pediatría-SSA, Fondos Federales 043-12. AR received the
346717 scholarship from Consejo Nacional de Ciencia y Tecnología (CONACyT). We thank S Becerra and J Yañez from IBT
UNAM for primer synthesis.
Author details
1Laboratorio de Citogenética, Departamento de Investigación en Genética Humana, Instituto Nacional de Pediatría, D.F.,
México. 2Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México, D.F., México.
3Instituto de Ecología, Universidad Nacional Autónoma de México, D.F., México. 4C3, Centro de Ciencias de la
Complejidad, Universidad Nacional Autónoma de México, D.F., México. 5Current address: INRIA, Virtual Plants Project
Team, UMR AGAP, Montpellier, France. 6Departamento de Ciencias de la Salud, Universidad Autónoma
Metropolitana-Iztapalapa, D.F., México. 7Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de
México, D.F., México.
Received: 26 May 2015 Accepted: 12 August 2015
References
1. Surralles J, Jackson SP, Jasin M, Kastan MB, West SC, Joenje H. Molecular cross-talk among chromosome fragility
syndromes. Genes Dev. 2004;18(12):1359–70.
2. Aurias A, Antoine JL, Assathiany R, Odievre M, Dutrillaux B. Radiation sensitivity of bloom’s syndrome lymphocytes
during S and G 2 phases. Cancer Genet Cytogenet. 1985;16(2):131–6.
3. Krepinsky AB, Heddle JA, German J. Sensitivity of Bloom’s syndrome lymphocytes to ethyl methanesulfonate. Hum
Genet. 1979;50(2):151–6.
4. Taylor AMR. Unrepaired DNA strand breaks in irradiated ataxia telangiectasia lymphocytes suggested from
cytogenetic observations. Mutat Res Fundam Mol Mech Mutagen. 1978;50(3):407–18.
5. German J, Reginald A, David B. Chromosomal breakage in a rare and probably genetically determined syndrome of
man. Science. 1965;148.3669:506–7.
6. German J, Sanz MM, Ciocci S, Ye TZ, Ellis NA. Syndrome causing mutations of the BLM gene in persons in the
Bloom’s Syndrome Registry. Hum Mutat. 2007;28(8):743–53.
7. Chaganti RSK, Schonberg S, German J. A manyfold increase in sister chromatid exchanges in Bloom’s syndrome
lymphocytes. Proc Natl Acad Sci. 1974;71(11):4508–12.
8. Tadjoedin MK, Fraser FC. Heredity of ataxia-telangiectasia (Louis-Bar syndrome). Am J Dis Child. 1965;110(1):64–8.
9. Concannon P, Gatti RA. Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum
Mutat. 1997;10(2):100.
10. Kojis TL, Gatti RA Sparkes, RS. The cytogenetics of ataxia telangiectasia. Cancer Genet Cytogenets. 1991;56(2):
143–156.
11. Oxford JM, Harnden DG, Parrington JM, Delhanty JD. Specific chromosome aberrations in ataxia telangiectasia.
J Med Genet. 1975;12(3):251–62.
12. Lobitz S, Velleuer E. Guido Fanconi (1892–1979): a jack of all trades. Nat Rev Cancer. 2006;6(11):893–8.
13. de Winter J, Joenje H. The genetic and molecular basis of Fanconi anemia. Mutat Res. 2009;668:11–9.
14. Kee Y, D’Andrea AD. Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev.
2010;24:1680–94.
15. Vaz F, Hanenberg H, Schuster B. Mutation of the RAD51C gene in a fanconi anemia-like disorder. Nat Genet.
2010;42:406–9.
16. Kim Y, Lach F, Desetty R, et al. Mutations of the SLX4 gene in fanconi anemia. Nat Genet. 2011;43:142–6.
17. Bogliolo M, Schuster B, Stoepker C, et al. Mutations in ERCC4, encoding the DNA-repair endonuclease XPF cause
Fanconi anemia. Am J Hum Genet. 2013;92:800–6.
Rodríguez et al. Theoretical Biology andMedical Modelling  (2015) 12:19 Page 21 of 22
18. Greenberg RA, Sawyer SL, Tian L, et al. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer
discov.2014;CD-14.
19. Hira A, Yoshida K, Sato K, Okuno Y, Shiraishi Y, Chiba K, et al. Mutations in the Gene Encoding the E2 Conjugating
Enzyme UBE2T Cause Fanconi Anemia. Am J Hum Genet. 2015;96(6):1001–7.
20. Schroeder TM, German J. Bloom’s syndrome and Fanconi’s anemia: demonstration of two distinctive patterns of
chromosome disruption and rearrangement. Humangenetik. 1974;25(4):299–306.
21. Auerbach A. Fanconi anemia and its diagnosis. Mutat Res. 2009;668:4–10.
22. Amor-Guéret M. Bloom syndrome, genomic instability and cancer: the SOS-like hypothesis. Cancer Lett. 2006;236(1):
1–12.
23. Soulier J. Fanconi anemia. Hematol Am Soc Hematol Educ Prog. 2011492–7.
24. Tulpule A, Lensch MW, Miller J, et al. Knockdown of Fanconi anemia genes in human embryonic stem cells reveals
early developmental defects in the hematopoietic lineage. Blood. 2011;115(17):3453–62.
25. Langevin F, Crossan GP, Rosado IV, et al. Fancd2 counteracts the toxic effects of naturally produced aldehydes in
mice. Nature. 2011;475:53–8.
26. Rosado IV, Langevin F, Crossan GP, et al. Formaldehyde catabolism is essential in cells deficient for the Fanconi
anemia DNA-repair pathway. Nat Struct Mol Biol. 2011;18:1432–4.
27. Ceccaldi R, Parmar K, Mouly E, et al. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21
DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell. 2012;11:36–49.
28. Heinrich M, Hoatlin ME, Zigler AJ, et al. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia
lymphoblasts reflects normal checkpoint function. Blood. 1998;91:275–87.
29. Freie B, Ciccone S, Li X, et al. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2
checkpoint. J Biol Chem. 2004;279:50986–93.
30. Neveling K, Endt D, Hoehn H, et al. Genotype-phenotype correlations in Fanconi anemia. Mutat Res. 2009;668:73–91.
31. Ceccaldi R, Briot D, Larghero J, et al. Spontaneous abrogation of the G2 DNA damage checkpoint has clinical
benefits but promotes leukemogenesis in Fanconi anemia patients. J Clin Invest. 2011;121:184–94.
32. Faure A, Naldi A, Chaouiya C, et al. Dynamical analysis of a generic boolean model for the control of the
mammalian cell cycle. Bioinformatics. 2006;22:e124–131.
33. Mendoza L. A network model for the control of the differentiation process in Th cells. Biosystems. 2006;84:101–14.
34. Zhang R, Shah MV, Yang J, et al. Network model of survival signaling in large granular lymphocyte leukemia. Proc
Natl Acad Sci USA. 2009;105:16308–13.
35. Chaves M, Albert R, Sontag E. Robustness and fragility of Boolean models for genetic regulatory networks. J Theor
Biol. 2005;235:431–49.
36. Christensen C, Thakar J, Albert R. Systems-level insights into cellular regulation: inferring, analyzing, and modelling
intracellular networks. IET Syst Biol. 2007;1:61–77.
37. Wu M, Yang X, Chan C. A dynamic analysis of IRS-PKR signaling in liver cells: a discrete modeling approach. PLoS
One. 2009;4(12):e8040.
38. Rodriguez A, Sosa D, Torres L, et al. A Boolean network model of the FA/BRCA pathway. Bioinformatics. 2012;28:
858–66.
39. van Vugt M, Yaffe M, et al. Cell cycle re-entry mechanisms after DNA damage checkpoints: Giving it some gas to
shut off the breaks. Cell Cycle. 2010;11:2097–101.
40. van Vugt MA, Gardino AK, Linding R, et al. A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1
and Chk2 to inactivate the G2/M DNA damage checkpoint. PLoS Biol. 2010;8:e1000287.
41. Halim V, Alvarez-Fernandez M, Xu YJ, et al. omparative phosphoproteomic analysis of checkpoint recovery
identifies new regulators of the DNA damage response. Sci Signal. 2013;6:rs9.
42. Medema RH, Macurek L. Checkpoint recovery in cells: how a molecular understanding can help in the fight against
cancer. F1000 Biol Rep. 2011;3.
43. Álvarez-Fernández M, Medema RH, Lindqvist A. Transcriptional regulation underlying recovery from a DNA
damage-induced arrest. Transcription. 2010;1:32–5.
44. Meetei AR, et al. A Human Orthologue of Archaeal DNA Repair Protein Hef is Defective in Fanconi Anemia
Complementation Group. M Nat Genet. 2005;37:958–63.
45. Kee Y, et al. Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis. Genes Dev. 2009;23:
555–60.
46. Wang XZ, et al. Chk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway. Mol
Cell Biol. 2007;27:3098–108.
47. Smogorzewska A, et al. Identification of the Fanconi anemia (FANC) I protein, a monoubiquitinated FANCD2 paralog
required for crosslink repair. Cell. 2007;129:289–301.
48. Bogliolo M, et al. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain
chromosome stability. EMBO J. 2007;26:1340–51.
49. Pace P, et al. Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway. Science. 2010;329:219–23.
50. Bhagwat N, et al. XPF-ERCC1 Participates in the Fanconi Anemia Pathway of Cross-Link Repair. Mol Cell Biol. 2009;29:
6427–37.
51. Hanada K, et al. The structure-specific endonuclease Mus81/Eme1 promotes conversion of interstrand DNA
crosslinks into double-strands breaks. EMBO J. 2006;25:492125–4932.
52. Lieber MR. The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway.
Annu Rev Biochem. 2010;79:181–211.
53. Chang DJ, Cimprich KA. DNA damage tolerance: when it’s OK to make mistakes. Nature Chem Biol. 2009;5:82–90.
54. Mirchandani KD, et al. The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci
assembly. DNA Repair. 2008;7:902–11.
55. Kass EM, Jasin M. Collaboration and competition between DNA double-strand break repair pathways. FEBS Letters.
2010;584:3703–8.
Rodríguez et al. Theoretical Biology andMedical Modelling  (2015) 12:19 Page 22 of 22
56. Adamo A, et al. Preventing Non-homologous End-Joining suppresses DNA repair defects of Fanconi Anemia. Mol
Cell. 2010;39:25–35.
57. Yaneva M, et al. Interaction of DNA-dependent protein kinase with DNA and with KU: biochemical and atomic-force
microscopy studies. EMBO J. 1997;16:5098–112.
58. Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol. 2008;9:616–127.
59. Collis SJ, et al. FANCM and FAAP24 function in ATR- Mediated Checkpoint Signaling Independently of the Fanconi
Anemia Core Complex. Mol Cel. 2008;32:313–24.
60. Jazayeri A, et al. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nature
Cell Biol. 2006;8:37–45.
61. Stiff T, et al. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork
stalling. EMBO J. 2006;25:5775–82.
62. Lavin MF. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene.
2008;26:7749–58.
63. Lee J, et al. The Rad9-Hus1-Rad1 Checkpoint Clamp regulates interaction of TopBP1 with ATR. J Biol Chem. 2007;282:
28036–44.
64. Shieh S, et al. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple
DNA damage-inducible sites. Genes Dev. 2000;14:289–300.
65. Bassermann F, Pagano M. Dissecting the role of ubiquitylation in the DNA damage response checkpoint in G2. Cell
Death Differ. 2010;17:78–85.
66. Mussel C, Hopfensitz M, Kestler HA. BoolNet-an R package for generation, reconstruction and analysis of Boolean
networks. Bioinformatics. 2010;26:1378–80.
67. Fenech M, Morley AA. Measurement of micronuclei in lymphocytes. Mutat Res. 1985;147:29–36.
68. Zhou B, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2000;408:433–9.
69. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001;27:
247–54.
70. Bloom J, Cross FR. Multiple levels of cyclin specificity in cell-cycle control. Nat Rev Mol Cell Biol. 2007;8:149–60.
71. Krenning L, Feringa FM, Shaltiel IA, et al. Transient activation of p53 in G2 phase is sufficient to induce senescence.
Molecular Cell. 2014;55:59–72.
72. Karlebach G, Shamir R. Modelling and analysis of gene regulatory networks. Nat Rev Mol Cell Biol. 2008;9(10):770–80.
73. Morris MK, Saez-Rodriguez J, Sorger PK, Lauffenburger DA. Logic-based models for the analysis of cell signaling
networks. Biochemistry. 2010;49(15):3216–24.
74. Tenazinha N, Vinga S. A survey on methods for modeling and analyzing integrated biological networks. IEEE/ACM
Trans Comput Biol Bioinforma (TCBB). 2011;8(4):943–58.
75. Bornholdt S. Boolean network models of cellular regulation: prospects and limitations. J R Soc Interface 5. 2008;1:
S85–S94.
76. Lazebnik Y. Can a biologist fix a radio?—or, what I learned while studying apoptosis. Biochemistry (Moscow).
2004;69(12):1403–6.
77. Tyson JJ, Chen KC, Novak B. Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways
in the cell. Curr Opin Cell Biol. 2003;15(2):221–31.
78. Wang AT, Smogorzewska A. SnapShot: Fanconi anemia and associated proteins. Cell. 2015;160(1):354.
79. Fritsch P, Craddock TJA, del Rosario RM, Rice MA, Smylie A, Folcik VA, et al. Succumbing to the laws of attraction:
Exploring the sometimes pathogenic versatility of discrete immune logic. Syst Biomed. 2013;1(3):179–94.
80. Peng A. Working hard for recovery: mitotic kinases in the DNA damage checkpoint. Cell Biosci. 2013;3:20.
81. Amador V, Ge S, Santamaría PG, et al. APCCDC20controls the ubiquitin-mediated degradation of p21 in
prometaphase. Mol Cell. 2007;3:462–73.
82. Mailand N, Bekker-Jensen S, Bartek J, et al. Destruction of Claspin by SCFbTrCP restrains Chk1 activation and
facilitates recovery from genotoxic stress. Mol Cell. 2006;23:307–18.
83. Liang H, Esposito A, De S, Ber S, Collin P, Surana U, et al. Homeostatic control of polo-like kinase-1 engenders
non-genetic heterogeneity in G2 checkpoint fidelity and timing. Nat Commun. 2014;5.
84. Shaltiel IA, Krenning L, Bruinsma W, Medema RH. The same, only different—DNA damage checkpoints and their
reversal throughout the cell cycle. J Cell Sci. 2015;128:607–20.
85. Lindqvist A, de Bruijn M, Macurek L, et al. Wip1 confers G2 checkpoint recovery competence by counteracting p53
dependent transcriptional repression. EMBO J. 2009;20:3196–206.
86. Shaltiel IA, Aprelia M, Saurin AT, et al. Distinct phosphatases antagonize the p53 response in different phases of the
cell cycle. Proc Natl Acad Sci USA. 2014;20:7313–8.
87. Seki A, Coppinger J, Jang C, et al. Bora and the kinase Aurora A cooperatively activate the kinase Plk1 and control
mitotic entry. Science. 2008;320:1655–8.
88. Macurek L, Lindqvist A, Lim D, et al. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery.
Nature. 2008;455:119–23.
89. van Vugt MA, Brás A, Medema RH. Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in
mammalian cells. Mol Cell. 2004;15(5):799–811.
